SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001561743-20-000035
Filing Date
2020-05-07
Accepted
2020-05-07 16:18:10
Documents
75
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q kin-20200331.htm   iXBRL 10-Q 1530086
2 EX-31.1 exhibit311q12020.htm EX-31.1 11216
3 EX-31.2 exhibit312q12020.htm EX-31.2 11387
4 EX-32.1 exhibit321q12020.htm EX-32.1 8255
  Complete submission text file 0001561743-20-000035.txt   7853019

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kin-20200331.xsd EX-101.SCH 45221
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kin-20200331_cal.xml EX-101.CAL 83844
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kin-20200331_def.xml EX-101.DEF 266090
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kin-20200331_lab.xml EX-101.LAB 589544
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kin-20200331_pre.xml EX-101.PRE 412311
66 EXTRACTED XBRL INSTANCE DOCUMENT kin-20200331_htm.xml XML 1643190
Mailing Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010
Business Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010 650-701-7901
Kindred Biosciences, Inc. (Filer) CIK: 0001561743 (see all company filings)

IRS No.: 461160142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36225 | Film No.: 20856694
SIC: 2834 Pharmaceutical Preparations